SCHEMBL767167

SCHEMBL767167

O=CCOc1[c]cccc1

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 3/20 0.36
▸ CTSK P43235 3/20 0.36
▸ CTSL P07711 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28290479 0.81 ALDH1A1 (0.33) ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL525712 0.80 — —
SCHEMBL482463 0.80 HPGD (0.39) ALDH1A1HPGD
SCHEMBL11171654 0.77 AOC3 (0.32) —
SCHEMBL27495269 0.77 AOC3 (0.32) —
SCHEMBL10397204 0.77 AOC3 (0.32) —
SCHEMBL10397205 0.77 AOC3 (0.32) —
SCHEMBL6727394 0.77 — —
SCHEMBL6238419 0.76 JAK2 (0.33) ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL1984410 0.76 MAOB (0.35) ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 — — US disclosed
US-20130245025-A1 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-09-19 — — US disclosed
EP-2619200-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2013-07-31 — — EP disclosed
US-8383670-B2 Trisubstituted thiophenes that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-02-26 — — US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 — — EP disclosed
WO-2012040511-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-29 — — WO disclosed
US-20120071516-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-22 — — US disclosed
US-20110212970-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-09-01 — — US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 — — WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed
US-7906553-B2 Substituted thiophene modulators of intracellular calcium CALCIMEDICA, INC. (US) 2011-03-15 — — US disclosed
US-20100261725-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2010-10-14 — — US disclosed
EP-0830638-B1 PRE-DYES AND COMPOSITIONS COMPRISING THEM KIMBERLY CLARK CO (US) 2000-08-23 — — EP disclosed
US-6063551-A A LEUCO DYE ASSOCIATED WITH A RADIATION TRANSORBER WHERE THE RADIATION TRANSORBER COMPRISES A WAVELENGTH-SELECTIVE SENSITIZER COVALENTLY BONDED TO A REACTIVE SPECIES-GENERATING PHOTOREACTOR; PHTHALOYLGLYCINE; 4-(4-HYDROXYPHENYL)BUT-2-ONE KIMBERLY-CLARK WORLDWIDE, INC. (US) 2000-05-16 — — US disclosed
US-5837429-A DYE COVALENTLY BOUND TO RADIATION TRANSORBER THAT IS COLORLESS AND WILL FORM COLOR WHEN IRRADIATED KIMBERLY-CLARK WORLDWIDE (US) 1998-11-17 — — US disclosed
US-5786132-A Pre-dyes, mutable dye compositions, and methods of developing a color KIMBERLY-CLARK CORPORATION (US) 1998-07-28 — — US disclosed
EP-0830638-A1 NOVEL PRE-DYES Kimberly-Clark Worldwide, Inc. (US) 1998-03-25 — — EP disclosed
WO-1996039646-A1 NOVEL PRE-DYES KIMBERLY-CLARK WORLDWIDE, INC. (US) 1996-12-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261725-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885
US-20110212970-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885
US-20130245025-A1 Compounds that modulate intracellular calcium ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885
US-20120071516-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CTSS 1220/4885CTSK 1533/4885CTSL 2660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback